COX-1和COX-2在哮喘发病机制中的作用及其在选择性抑制剂使用中的意义。 - Suppr

Suppr

超能文献

The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors.

作者信息

Szczeklik A, Sanak M

出版信息

Clin Exp Allergy. 2002 Mar;32(3):339-42. doi: 10.1046/j.1365-2222.2002.01333.x.

DOI:10.1046/j.1365-2222.2002.01333.x

PMID:11940059

Abstract

摘要

相似文献

The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors.

Clin Exp Allergy. 2002 Mar;32(3):339-42. doi: 10.1046/j.1365-2222.2002.01333.x.

COX-1 and COX-2 inhibition: current status and future perspective.

Acta Anaesthesiol Belg. 1998;49(3):175-83.

Selective cyclooxygenase-2 inhibitors as potential therapeutic agents for inflammatory diseases.

Adv Exp Med Biol. 1997;407:157-61. doi: 10.1007/978-1-4899-1813-0_24.

Cyclooxygenase inhibition for postoperative analgesia.

Anesth Analg. 2002 Jul;95(1):169-76. doi: 10.1097/00000539-200207000-00030.

The discovery and function of COX-2.

J Rheumatol Suppl. 1997 Jul;49:6-8.

COX-2 inhibitors: a review.

Pediatr Emerg Care. 2004 Jun;20(6):396-9; quiz 400-2. doi: 10.1097/01.pec.0000133618.36861.73.

Cyclooxygenase-2 inhibitors in aspirin-induced asthma.

Chest. 2003 Apr;123(4):1317-8; author reply 1318. doi: 10.1378/chest.123.4.1317.

[Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors].

Pharm Unserer Zeit. 2002;31(2):190-8. doi: 10.1002/1615-1003(200203)31:2<190::AID-PAUZ190>3.0.CO;2-S.

Cyclooxygenase-2 inhibitors in aspirin-sensitive asthma.

Chest. 2003 Jun;123(6):2155-6; author reply 2156. doi: 10.1378/chest.123.6.2155.

Non-steroidal anti-inflammatory drugs: back to the future.

Rheumatology (Oxford). 1999 Aug;38(8):693-6. doi: 10.1093/rheumatology/38.8.693.

引用本文的文献

Expression of COX-1, COX-2, 5-LOX and in nasal polyps and bronchial tissue of patients with aspirin exacerbated airway disease.

Allergy Asthma Clin Immunol. 2019 Dec 26;15:83. doi: 10.1186/s13223-019-0395-5. eCollection 2019.

Samter's Triad: State of the Art.

Clin Exp Otorhinolaryngol. 2018 Jun;11(2):71-80. doi: 10.21053/ceo.2017.01606. Epub 2018 Apr 13.

Aspirin Intolerance: Experimental Models for Bed-to-Bench.

Curr Drug Targets. 2016;17(16):1963-1970. doi: 10.2174/1389450117666161005152327.

Dynamic model of eicosanoid production with special reference to non-steroidal anti-inflammatory drug-triggered hypersensitivity.

IET Syst Biol. 2015 Oct;9(5):204-15. doi: 10.1049/iet-syb.2014.0037.

Prostaglandin-endoperoxide synthase genes COX1 and COX2 - novel modifiers of disease severity in cystic fibrosis patients.

J Appl Genet. 2010;51(3):323-30. doi: 10.1007/BF03208862.

Aspirin-exacerbated asthma.

Allergy Asthma Clin Immunol. 2008 Jun 15;4(2):75-83. doi: 10.1186/1710-1492-4-2-75.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors.

Clin Exp Allergy. 2002 Mar;32(3):339-42. doi: 10.1046/j.1365-2222.2002.01333.x.

COX-1 and COX-2 inhibition: current status and future perspective.

Acta Anaesthesiol Belg. 1998;49(3):175-83.

Selective cyclooxygenase-2 inhibitors as potential therapeutic agents for inflammatory diseases.

Adv Exp Med Biol. 1997;407:157-61. doi: 10.1007/978-1-4899-1813-0_24.

Cyclooxygenase inhibition for postoperative analgesia.

Anesth Analg. 2002 Jul;95(1):169-76. doi: 10.1097/00000539-200207000-00030.

The discovery and function of COX-2.

J Rheumatol Suppl. 1997 Jul;49:6-8.

COX-2 inhibitors: a review.

Pediatr Emerg Care. 2004 Jun;20(6):396-9; quiz 400-2. doi: 10.1097/01.pec.0000133618.36861.73.

Cyclooxygenase-2 inhibitors in aspirin-induced asthma.

Chest. 2003 Apr;123(4):1317-8; author reply 1318. doi: 10.1378/chest.123.4.1317.

[Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors].

Pharm Unserer Zeit. 2002;31(2):190-8. doi: 10.1002/1615-1003(200203)31:2<190::AID-PAUZ190>3.0.CO;2-S.

Cyclooxygenase-2 inhibitors in aspirin-sensitive asthma.

Chest. 2003 Jun;123(6):2155-6; author reply 2156. doi: 10.1378/chest.123.6.2155.

Non-steroidal anti-inflammatory drugs: back to the future.

Rheumatology (Oxford). 1999 Aug;38(8):693-6. doi: 10.1093/rheumatology/38.8.693.

引用本文的文献

Expression of COX-1, COX-2, 5-LOX and in nasal polyps and bronchial tissue of patients with aspirin exacerbated airway disease.

Allergy Asthma Clin Immunol. 2019 Dec 26;15:83. doi: 10.1186/s13223-019-0395-5. eCollection 2019.

Samter's Triad: State of the Art.

Clin Exp Otorhinolaryngol. 2018 Jun;11(2):71-80. doi: 10.21053/ceo.2017.01606. Epub 2018 Apr 13.

Aspirin Intolerance: Experimental Models for Bed-to-Bench.

Curr Drug Targets. 2016;17(16):1963-1970. doi: 10.2174/1389450117666161005152327.

Dynamic model of eicosanoid production with special reference to non-steroidal anti-inflammatory drug-triggered hypersensitivity.

IET Syst Biol. 2015 Oct;9(5):204-15. doi: 10.1049/iet-syb.2014.0037.

Prostaglandin-endoperoxide synthase genes COX1 and COX2 - novel modifiers of disease severity in cystic fibrosis patients.

J Appl Genet. 2010;51(3):323-30. doi: 10.1007/BF03208862.

Aspirin-exacerbated asthma.

Allergy Asthma Clin Immunol. 2008 Jun 15;4(2):75-83. doi: 10.1186/1710-1492-4-2-75.